XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.2.u1

REVENUE (Tables)

9 Months Ended

Jul. 31, 2024

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following table presents the company’s total revenue and segment revenue disaggregated by geographical region:

			Three Months Ended July 31,
			2024																								2023
			Life Sciences and Applied Markets						Agilent CrossLab						Diagnostics and Genomics						Total						Life Sciences and Applied Markets						Agilent CrossLab						Diagnostics and Genomics						Total
			(in millions)
Revenue by Region
Americas			$	251					$	170					$	205					$	626					$	270					$	159					$	238					$	667
Europe			193						113						126						432						203						108						121						432
Asia Pacific			338						128						54						520						381						129						63						573
Total			$	782					$	411					$	385					$	1,578					$	854					$	396					$	422					$	1,672

			Nine Months Ended July 31,
			2024																								2023
			Life Sciences and Applied Markets						Agilent CrossLab						Diagnostics and Genomics						Total						Life Sciences and Applied Markets						Agilent CrossLab						Diagnostics and Genomics						Total
			(in millions)
Revenue by Region
Americas			$	735					$	501					$	657					$	1,893					$	819					$	467					$	744					$	2,030
Europe			605						335						376						1,316						649						309						363						1,321
Asia Pacific			1,042						382						176						1,600						1,203						388						203						1,794
Total			$	2,382					$	1,218					$	1,209					$	4,809					$	2,671					$	1,164					$	1,310					$	5,145

The following table presents the company’s total revenue disaggregated by end markets and by revenue type:

			Three Months Ended												Nine Months Ended
			July 31,												July 31,
			2024						2023						2024						2023
			(in millions)
Revenue by End Markets
Pharmaceutical			$	540					$	592					$	1,647					$	1,843
Chemicals and Advanced Materials			356						378						1,110						1,162
Diagnostics and Clinical			242						241						709						730
Food			144						151						440						472
Academia and Government			128						146						417						451
Environmental and Forensics			168						164						486						487
Total			$	1,578					$	1,672					$	4,809					$	5,145
Revenue by Type
Instrumentation			$	556					$	643					$	1,734					$	2,091
Non-instrumentation and other			1,022						1,029						3,075						3,054
Total			$	1,578					$	1,672					$	4,809					$	5,145

Contract Liabilities and Changes in Balances

The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the nine months ended July 31, 2024:

						Contract Liabilities
						(in millions)
Ending balance as of October 31, 2023						$	616
Net revenue deferred in the period						456
Revenue recognized that was included in the contract liability balance at the beginning of the period						(422)
Change in deferrals from customer cash advances, net of revenue recognized						(8)
Currency translation and other adjustments						4
Ending balance as of July 31, 2024						$	646

X

- Definition

Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-10

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration